https://www.avient.com/sites/default/files/2024-12/Terms and Conditions of Sale for France.pdf
The sale of Products or the providing of samples or developmental
material shall not, by implication or otherwise, convey any license under any intellectual property right relating to the
compositions and/or applications of the Products, sample, or developmental material, as applicable.
If any provision of these Terms is found to be invalid, the validity of all
other provisions shall not be affected and the rest of the Terms shall continue to apply.
25.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520PolyOne%2520Distribution.pdf
Schuering
Page 77
Appliance
5%
Building &
Construction
3% Wire & Cable
3%
Electrical &
Electronics
3%
Consumer
21%
Industrial
24%
HealthCare
21%
Transportation
17%
2011 Revenue: $1.0 Billion2011 Revenue: $1.0 Billion Key SuppliersKey Suppliers
At a Glance
Distribution
Packaging
3%
2.6%
3.0%
3.5%
4.0% 4.6%
5.6%
2006 2007 2008 2009 2010 2011 2015
Operating Income % of Sales
ROICROIC Expanding ProfitsExpanding Profits
15.3%
18.4%
22.4%
30.0%
39.2%
48.6%
2006 2007 2008 2009 2010 2011
Target
6 – 7.5%
Page 78
Value Proposition and Transformation Highlights
Distribution
Value Proposition
• North America-based distributor with expanding global reach providing
key plastic processors and market segments with best-in-class suppliers
products, service and delivery with a commitment to develop value-added
solutions to enhance customer profitability
Transformation Highlights
• Significant market share gains with key suppliers
,
> $5B Addressable Market
• Significant market share gains with key suppliers
� Proprietary PolyOne technology
� Dow Corning
• Improved sales mix and profitability by shifting to
non-cyclical businesses like healthcare
• Established presence in Brazil and Asia in 2011
Page 79
Key Differentiators
Distribution
• Product offering
� Breadth and depth; industry leading suppliers
• Sales and marketing capability
• Customer service / logistics operations
� Customer survey results – consistent best-in-class performance
� Leading on-time delivery
• Management team experience and stability
• Lean Six Sigma
� Solving our customers’ unmet needs
Page 80
$102.8
$207.2
2006 2011
Healthcare Revenue
• Strong market segmentation
provides focused resourcing
to accelerate growth
• Expanding global reach meets
Areas of Focus
Distribution
2006 2011
$66.0
$182.4
2006 2011
National Accounts Revenue
• Expanding global reach meets
customers’ needs and creates
competitive differentiation
• Selling skills & product
application knowledge to
target executives & engineers
($ millions)
Page 81
Critical Imperatives
• Invest in commercial resources to accelerate growth
• Expand healthcare and key account revenues
• Broaden geographic reach and develop new markets and
channel partnerships
Critical Imperatives and 2015 Goal
Distribution
channel partnerships
• Continue to improve working capital efficiency
and superior cash flow generation
2015 Goal
• 6 - 7.5% return on sales
Page 82
Page 83
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Commercial%2520Excellence.pdf
Kahler
(16) Page 16
• Shifted sales compensation
practices to drive value and
margin expansion
• Significantly upgraded and
added sales, marketing, and
From Volume to Value
$2,622
$3,060
Sales
($ millions) 2006 2011PFadded sales, marketing, and
technical resources
• Expanded global cross-selling
• Invested in training and tools
2006 2011PF
3.3%
6.8%
2006 2011PF
Adjusted OI%
($ millions) 2006 2011PF
2006 2011PF
Page 17
• Value pricing practices enabled
by use of EVE tools
• Shifting the basis of
competition to specialization
1.5%
8.9%
2006 2011PF
Specialty OI%
Specialization Drives Margin Expansion
2006 2011PF
7.2%
PPS OI%
competition to specialization
differentiates PolyOne as a
value-added solutions provider
• Redirecting our technology and
marketing focus to the most
attractive segments 2.6%
5.6%
2006 2011
POD OI%
5.5%
7.2%
2006 2011
2006 2011
2006 2011
Page 18
• Global key account management
team focused on key markets
and strategic OEMs
• Drive growth in target markets
through application development750
1,120
Total Commercial Employees 2007 – 2011
49% Increase
Commercial Excellence – Recent Investments
*Includes ColorMatrix
through application development
• Leverage breadth of solutions
across all PolyOne platforms to
identify innovative solutions for
strategic OEMs and
Tier 1 partners
*
750
2007 2011
Sales Marketing R&D/Tech
Page 19
5%
1%
0%
27%
2%
12% 4%
Performance Dashboards Drive Execution
45%
26% 18%
5%
55%
Page 20
53%
Drivers of Customer Loyalty
Customer Experience is Key to Customer Loyalty
53%
Building Customer Loyalty
n = 4,960 B2B customers of 24 companies
Source: Corporate Executive Board
Company
and Brand
Impact
Product
and
Service
Delivery
Value-to-
Price Ratio
Customer
Experience
19%
9%
9%
19%
19%
9%
Page 21
• Continue to redirect our focus to more attractive
segments and increase customer loyalty
and retention
• Leverage new commercial tools and investments
to enable disciplined execution and accountability
Critical Imperatives
to enable disciplined execution and accountability
• Position PolyOne as the differentiated
value-added specialty solutions provider
Drive improved mix in all segments and
achieve margin and profitability growth
Page 22
Page 23
https://www.avient.com/sites/default/files/2021-09/nonwoven-colorants-card.pdf
The portfolio also benefits from
excellent service and regulatory support from
experts in fiber coloration and enhancement.
https://www.avient.com/sites/default/files/2022-09/54139-Certificate-29AUG2022%5B98%5D.pdf
COMPOUND, SUPPLY AND PROTOTYPING SERVICES OF THERMOPLASTICS FOR THE MEDICAL DEVICE
INDUSTRY
Certificate Of Conformance
https://www.avient.com/sites/default/files/resources/NEU%2520ISO%25209001-2015%2520Exp%25201-22%2520%25281%2529.pdf
COMPOUND AND SUPPLY OF THERMOPLASTICS FOR THE MEDICAL DEVICE INDUSTRY.
https://www.avient.com/sites/default/files/2022-03/Trilliant HC Conductive Pipette Tips Application Snapshot.pdf
https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/trilliant-hc-healthcare-thermoplastics
https://www.avient.com/sites/default/files/2020-10/case-study-one-pager-trilliant-xr-xray-glasses.pdf
M E D I C A L E Q U I P M E N T
M A N U FA C T U R E R
S U R G I C A L X - R A Y G L A S S E S
• Replace lead while providing uniform shielding
performance
• Radiation shielding up to 140KeV
• Improve glasses design
• Compliance with Radiation Protection Regulation: Adult
eye exposure must be below 20 mSv per calendar year
• Conducted extensive testing to ensure comparable and
uniform shielding performance
• Improved geometric flexibility
• Lowered shielding component costs 30-50% by
eliminating machining and assembly steps (associated
with lead)
• Reduced weight of the glasses and enabled a more
ergonomic design
• Eliminated disposal concerns associated with lead
Trilliant™ XR Lead Replacement
Thermoplastics
KEY REQUIREMENTS
WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/trilliant-xr-ct-and-mri-scanners.pdf
Trilliant XR - CT and MRI Scanners
M E D I C A L D E V I C E
M A N U FAC T U R E R
M R I A N D C T S C A N N E R S
• Uniform shielding with no “hot spots”
• X-ray shielding up to 140 KeV
• Meet European Union’s Restriction of Hazardous
Substances (RoHS) future compliance requirements
• Provided a lead alternative solution that
delivered improved geometric flexibility for
more uniform radiation shielding
• Lowered shielding component costs 30-50%
by eliminating machining and assembly steps
Trilliant™ XR Lead Replacement
Thermoplastics
KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2021-08/versaflex-machine-cover-case-study-one-pager.pdf
https://www.avient.com/products/thermoplastic-elastomers/tpe-knowledge-center/overmolding-solutions